Overview
Fanglei Zuo practices practicing medicine in Haidian, China.
Their clinical expertise encompasses Severe Acute Respiratory Syndrome (SARS), COVID-19, Primary Immunodeficiency (PID), and Ataxia-Telangiectasia.
They are actively involved in clinical research, co-authoring 45 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Fanglei L. Zuo
Is Fanglei L. Zuo a top-rated expert for Severe Acute Respiratory Syndrome (SARS)?
MediFind is an objective health platform that identifies experts based on real-world data. Fanglei L. Zuo is classified as an Experienced expert for Severe Acute Respiratory Syndrome (SARS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Fanglei L. Zuo participate in research or clinical trials?
Yes. Fanglei L. Zuo has published 45 articles and abstracts on conditions like Severe Acute Respiratory Syndrome (SARS). You can view a list of Fanglei L. Zuo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Ataxia-TelangiectasiaZuo isExperienced. Learn about Ataxia-Telangiectasia.
- COVID-19Zuo isExperienced. Learn about COVID-19.
- Helicobacter Pylori Infection
- Primary Immunodeficiency (PID)
- Severe Acute Respiratory Syndrome (SARS)